Sorry, Readability was unable to parse this page for content.
Hasnat Khan Olivia Nuzzi Nick Jonas Justin Bieber Spits On Fans Riley Cooper Aaron Paul loretta lynn
Wednesday, July 31, 2013
L'acteur Denzel Washington sera de retour sur les planches de Broadway
NEW YORK, ?tats-Unis - L'acteur Denzel Washington foulera ? nouveau les planches sur Broadway, mais ce ne sera pas pour y chanter.
S'affichant lundi aux c?t?s de son ?pouse, Pauletta Pearson, sur le tapis rouge de la premi?re mondiale de son dernier film ?2 Guns?, l'acteur a r?v?l? qu'il serait de la distribution d'une reprise d'une pi?ce de Lorraine Hansberry, ?A Raisin in the Sun?.
Le laur?at d'un Oscar et d'un Tony a pr?cis? que les g?n?rales d?buteraient en mars.
Justifiant sa d?cision de renouer avec le th??tre, Denzel Washington a expliqu? qu'il tentait de garder le rythme avec son ?pouse, qui en fait ?beaucoup plus que (lui)?.
Il a ensuite indiqu? que lui et sa femme se rendraient en Caroline du Nord pour le National Black Theate Festival. Pauletta Pearson y jouera dans une pi?ce aur?ol? de succ?s, ?Power Play?.
Denzel Washington a ?galement soulign?, sous le regard amus? de son ?pouse, qu'il aimerait lui aussi, un jour, chanter.
?Je veux juste lui enlever un talent. Elle sait que je ne chante pas. Mais elle-m?me le peut?, a-t-il lanc?.
Alors que le couple s'?loignait, l'acteur de 58 ans a pr?cis? ? la blague qu'il pouvait chanter sous la douche.
"; var coords = [-5, -72]; // display fb-bubble FloatingPrompt.embed(this, html, undefined, 'top', {fp_intersects:1, timeout_remove:2000,ignore_arrow: true, width:236, add_xy:coords, class_name: 'clear-overlay'}); });
Source: http://quebec.huffingtonpost.ca/2013/07/31/lacteur-denzel-washingto_n_3682523.html
elizabeth smart chipotle Shakira Farrah Abraham Sex Tape Met gala lauryn hill teacher appreciation week
SEC sues ex-Santander executive, ex-Spanish judge for insider trading
By Jonathan Stempel
NEW YORK (Reuters) - The U.S. Securities and Exchange Commission has charged a former Banco Santander SA executive and a former Spanish judge with insider trading over a proposed takeover of Potash Corp of Saskatchewan Inc on which the Spanish bank had given investment banking advice.
In a lawsuit filed on Tuesday in U.S. District Court in New York, the SEC is seeking to recover nearly $1 million of alleged illegal profit by Cedric Ca?as Maillard, a former adviser to Banco Santander's chief executive, and Julio Mar?n Ugedo, the former judge.
According to the SEC, Ca?as, 40, had learned on August 5, 2010, that Santander was helping Anglo-Australian mining giant BHP Billiton Ltd prepare a bid for Potash, a fertilizer company based in Saskatoon, Saskatchewan.
The SEC said that Ca?as, a Harvard Business School graduate, then tipped the acquisition to Mar?n, 42, a close friend with whom he had grown up and still talked to by phone, text message or email dozens of times a month.
According to the SEC, Ca?as soon bought the equivalent of 30,000 Potash shares through contracts-for-difference (CFD), which are leveraged securities not traded in the United States, and Mar?n bought 1,393 Potash shares. It said Mar?n has admitted to discussing Potash with Ca?as before making that purchase.
On August 17, 2010, Potash rejected an unsolicited $38.6 billion takeover from BHP Billiton, but the news caused Potash's share price to shoot up more than 25 percent that day.
The SEC said Ca?as and Mar?n quickly sold their securities, realizing respective net profits of $917,239 and $43,566. It seeks to recover those sums and impose civil fines.
"Ca?as used his position as an insider at an investment bank to trade CFDs based on confidential information," Daniel Hawke, chief of the SEC's market abuse unit, said. "To those who think they can mask their insider trading by trading CFDs rather than the underlying equity security, this case demonstrates our resolve to detect such trading and hold them accountable."
The SEC said Ca?as left his job at Santander in 2011 and now lives in Madrid, while Mar?n lives in Badajoz, Spain.
It is unclear whether the defendants have hired lawyers. Neither could immediately be reached for comment. Santander spokeswoman Julia Hayley declined to comment.
In April 2011, the SEC said former Santander analyst Juan Jose Fernandez Garcia agreed to pay more than $626,000 in disgorged profit and fines to settle insider trading charges relating to Potash. He did not admit or deny wrongdoing.
Canada ultimately blocked the Potash takeover on the ground that it did not provide a "net benefit" to the country.
The case is SEC v. Ca?as Maillard et al, U.S. District Court, Southern District of New York, No. 13-05299.
(Reporting by Jonathan Stempel; Editing by Bernard Orr)
Source: http://news.yahoo.com/sec-sues-ex-santander-executive-ex-spanish-judge-210303078.html
Jordyn Wieber michael phelps Kerri Strug Ledecky Nadia Comaneci Rebecca Soni Snoop Lion
Apple: 'Average' iPad toiler does a mere 46-hour week ? Register
Sorry, Readability was unable to parse this page for content.
Source: http://theglobalvillageweb.com/news/apple-average-ipad-toiler-does-a-mere-46-hour-week-register/
benjamin netanyahu storm shelters nick lachey lifelock chevy volt christina hendricks camp david
Estimate of French diamond heist balloons to $136 million
PARIS (AP) ? Wearing a scarf to mask his face, the gunman held up at least three security guards and then fled the luxury Cannes hotel roughly a minute later with $136 million in diamond jewelry, more than twice the initial estimated worth of the loot.
The simple, speedy theft is the biggest jewelry heist in years. Police had previously said Sunday's theft at the Carlton Intercontinental Hotel had netted ?40 million ($53 million) worth of treasure ? even at that level a major haul. Reached by The Associated Press, Philippe Vique, an assistant prosecutor in the Riviera town of Grasse, said the Dubai-based organizer of the diamond show had since raised the value based on a more complete inventory.
Vieques described a canny, but quick and logistically simple, break-in. The suspect somehow got in through the hotel's locked French doors, which open onto Cannes' famed Croisette promenade, then held up the participants of the show with a handgun and fled on foot. The hold-up itself took about a minute, all with three private security guards, two vendors and a manager of the sale-exhibit on hand, he said.
No customers were present at the time.
"He took a bag containing a briefcase and a small box, and then fled by another French door on the inside," Vique said. "He left on foot ... it was very fast."
The bag contained rings, earrings and pendants, Vique said. As the suspect began his getaway, a few jewels spilled out of the bag of loot and were quickly recovered.
"I wouldn't say it was easily done ? opening a locked door..." Vique said. "He found a way to open it. Why was he able to open this door?"
The jewelry was part of a display centering on the prestigious Leviev diamond house, which is owned by Israeli billionaire Lev Leviev. It was to run until the end of August.
A Leviev spokesman declined to comment. A day earlier, the company issued a statement saying its officials were cooperating with authorities and were relieved that no one was injured in the robbery.
The hotel, in a statement, confirmed the robbery and said none of its employees or guests "were involved in or affected by the incident." The Carlton said it was cooperating with police and would not comment further on the criminal investigation.
Jonathan Sazonoff, U.S. editor for the Museum Security Network website and an authority on high-value crime, told the AP on Sunday that police were likely to probe whether the heist was linked to recent jail escapes by alleged members of the Pink Panther jewel thief gang.
Vique said authorities were pursuing all possible leads and reviewing surveillance video footage, notably from cameras put in place by Cannes municipal authorities. But he said there was no indication so far that the suspect had links to any organized crime group.
The luxury hotel featured prominently in Alfred Hitchcock's "To Catch a Thief," starring Cary Grant as a reformed burglar chasing a jewel thief. Beyond the fiction, the Carlton has already been hit by a jewelry theft: In 1994, machine-gun-toting thieves stole $45 million in gems from the hotel ? an ornate, opulent fixture of the city's most-renowned boulevard. Stars throng the hotel each year for the Cannes Film Festival, and tourists rich and middle-class alike are common.
Source: http://news.yahoo.com/estimate-french-diamond-heist-raised-136m-144323947.html
nashville weather jason varitek andrew breitbart dead sheriff joe arpaio limbaugh aaron smith wilt chamberlain
Tuesday, July 30, 2013
India, Pakistan drawn up in same group in 2015 Cricket World Cup http://bit.l...
Sorry, Readability was unable to parse this page for content.
Michael Strahan Griselda Blanco Michelle Obama Speech Michael Clarke Duncan Nazanin Boniadi Deval Patrick Dedication 4
Plant-based compound may inhibit HIV
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sULOQz1yb0X367XvBC6VDr5UnTY4tZ7rZpoVmq7_Rt2pWj_PACAA-8_uJj6jL78mFOuqo1gIopIIb8tyCG23jDrdOrUq56Y3C45nKw4wI=s0-d){kind=small}
Public release date: 29-Jul-2013[ | E-mail |
Share ] Contact: Michele McDonald
mmcdon15@gmu.edu
703-993-8781
George Mason University
George Mason University research
A compound found in soybeans may become an effective HIV treatment without the drug resistance issues faced by current therapies, according to new research by George Mason University researchers.
It's in the early stages, but genistein, derived from soybeans and other plants, shows promise in inhibiting the HIV infection, says Yuntao Wu, a professor with the George Mason-based National Center for Biodefense and Infectious Diseases and the Department of Molecular and Microbiology.
Still, that doesn't mean people should begin eating large amounts of soy products. "Although genistein is rich in several plants such as soybeans, it is still uncertain whether the amount of genistein we consume from eating soy is sufficient to inhibit HIV," Wu says.
Genistein is a "tyrosine kinase inhibitor" that works by blocking the communication from a cell's surface sensors to its interior. Found on a cell's surface, these sensors tell the cell about its environment and also communicate with other cells. HIV uses some of these surface sensors to trick the cell to send signals inside. These signals change cell structure so that the virus can get inside and spread infection.
But genistein blocks the signal and stops HIV from finding a way inside the cell. It takes a different approach than the standard antiretroviral drug used to inhibit HIV.
"Instead of directly acting on the virus, genistein interferes with the cellular processes that are necessary for the virus to infect cells," Wu says. "Thus, it makes the virus more difficult to become resistant to the drug. Our study is currently it its early stage. If clinically proven effective, genistein may be used as a complement treatment for HIV infection."
Wu sees possibilities in this plant-based approach, which may address drug toxicity issues as well. Because genistein is plant-derived, it may be able to sidestep drug toxicity, a common byproduct of the daily and lifelong pharmaceutical regimen faced by patients with HIV to keep the disease at bay, Wu says. Typically, patients take a combination of multiple drugs to inhibit the virus. The frequency can lead to drug toxicity. Plus, HIV mutates and becomes drug-resistant.
Wu and his team are working at finding out how much genistein is needed to inhibit HIV. It's possible that plants may not have high enough levels, so drugs would need to be developed, Wu says.
Wu's research is feeling the financial squeeze these days due to sequestration and budget cuts within the National Institutes of Health, he says. His lab has turned to novel ways to fund the HIV research, including the genistein project. A bicycle ride dubbed NYC DC AIDS Research Ride raised money for Wu's lab a few years ago and has stepped up its efforts with a new fundraiser.
###
Other George Mason researchers on the genistein project include Jia Guo, Taban Rasheed, Alyson Yoder, Dongyang Yu, Huizhi Liang, Fei Yi and Todd Hawley.Xuehua Xu and Tian Jin from the National Institute of Allergy and Infectious Diseases in Rockville, Md., and Binhua Ling from Tulane University Health Sciences Center are also working on the research.
About George Mason University
George Mason University is an innovative, entrepreneurial institution with global distinction in a range of academic fields. Located in Northern Virginia near Washington, D.C., Mason provides students access to diverse cultural experiences and the most sought-after internships and employers in the country. Mason offers strong undergraduate and graduate degree programs in engineering and information technology, organizational psychology, health care and visual and performing arts. With Mason professors conducting groundbreaking research in areas such as climate change, public policy and the biosciences, George Mason University is a leading example of the modern, public university. George Mason UniversityWhere Innovation Is Tradition.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 29-Jul-2013[ | E-mail |
Share ] Contact: Michele McDonald
mmcdon15@gmu.edu
703-993-8781
George Mason University
George Mason University research
A compound found in soybeans may become an effective HIV treatment without the drug resistance issues faced by current therapies, according to new research by George Mason University researchers.
It's in the early stages, but genistein, derived from soybeans and other plants, shows promise in inhibiting the HIV infection, says Yuntao Wu, a professor with the George Mason-based National Center for Biodefense and Infectious Diseases and the Department of Molecular and Microbiology.
Still, that doesn't mean people should begin eating large amounts of soy products. "Although genistein is rich in several plants such as soybeans, it is still uncertain whether the amount of genistein we consume from eating soy is sufficient to inhibit HIV," Wu says.
Genistein is a "tyrosine kinase inhibitor" that works by blocking the communication from a cell's surface sensors to its interior. Found on a cell's surface, these sensors tell the cell about its environment and also communicate with other cells. HIV uses some of these surface sensors to trick the cell to send signals inside. These signals change cell structure so that the virus can get inside and spread infection.
But genistein blocks the signal and stops HIV from finding a way inside the cell. It takes a different approach than the standard antiretroviral drug used to inhibit HIV.
"Instead of directly acting on the virus, genistein interferes with the cellular processes that are necessary for the virus to infect cells," Wu says. "Thus, it makes the virus more difficult to become resistant to the drug. Our study is currently it its early stage. If clinically proven effective, genistein may be used as a complement treatment for HIV infection."
Wu sees possibilities in this plant-based approach, which may address drug toxicity issues as well. Because genistein is plant-derived, it may be able to sidestep drug toxicity, a common byproduct of the daily and lifelong pharmaceutical regimen faced by patients with HIV to keep the disease at bay, Wu says. Typically, patients take a combination of multiple drugs to inhibit the virus. The frequency can lead to drug toxicity. Plus, HIV mutates and becomes drug-resistant.
Wu and his team are working at finding out how much genistein is needed to inhibit HIV. It's possible that plants may not have high enough levels, so drugs would need to be developed, Wu says.
Wu's research is feeling the financial squeeze these days due to sequestration and budget cuts within the National Institutes of Health, he says. His lab has turned to novel ways to fund the HIV research, including the genistein project. A bicycle ride dubbed NYC DC AIDS Research Ride raised money for Wu's lab a few years ago and has stepped up its efforts with a new fundraiser.
###
Other George Mason researchers on the genistein project include Jia Guo, Taban Rasheed, Alyson Yoder, Dongyang Yu, Huizhi Liang, Fei Yi and Todd Hawley.Xuehua Xu and Tian Jin from the National Institute of Allergy and Infectious Diseases in Rockville, Md., and Binhua Ling from Tulane University Health Sciences Center are also working on the research.
About George Mason University
George Mason University is an innovative, entrepreneurial institution with global distinction in a range of academic fields. Located in Northern Virginia near Washington, D.C., Mason provides students access to diverse cultural experiences and the most sought-after internships and employers in the country. Mason offers strong undergraduate and graduate degree programs in engineering and information technology, organizational psychology, health care and visual and performing arts. With Mason professors conducting groundbreaking research in areas such as climate change, public policy and the biosciences, George Mason University is a leading example of the modern, public university. George Mason UniversityWhere Innovation Is Tradition.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2013-07/gmu-pcm072913.php
halle berry kurt cobain Kamala Harris URI Facebook Home Ncaa Basketball Tournament 2013 Robert Ebert
Subscribe to:
Posts (Atom)